Pharmabiz

China NMPA grants marketing authorization to Bayer’s asundexian, a selective, once-daily oral Factor XIa inhibitor to reduce risk of stroke

China NMPA grants marketing authorization to Bayer’s asundexian, a selective, once-daily oral Factor XIa inhibitor to reduce risk of stroke: Berlin Wednesday, October 28, 2026, ...
Pharmabiz

TN IDMA elects new office-bearers; J Jayaseelan elevated to IDMA South Zone vice-president

TN IDMA elects new office-bearers; J Jayaseelan elevated to IDMA South Zone vice-president: Peethaambaran Kunnathoor, Chennai Wednesday, October 28, 2026, 08:00 Hrs [IST] In a maj ...
Pharmabiz

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA: Our Bureau, New Delhi Wednesday, ...
Pharmabiz

Lions Club of Byculla donates neurosurgical equipment worth Rs.1.16 crore to Bai Jerbai Wadia Hospital for Children

Lions Club of Byculla donates neurosurgical equipment worth Rs.1.16 crore to Bai Jerbai Wadia Hospital for Children: Our Bureau, Mumbai Wednesday, October 28, 2026, 14:45 Hrs [IST ...
Pharmabiz

CSOs and patient groups welcomes IPO's rejection of patent for multi-drug resistant regimen BPaL

CSOs and patient groups welcomes IPO's rejection of patent for multi-drug resistant regimen BPaL: Our Bureau, New Delhi Wednesday, October 28, 2026, 14:10 Hrs [IST] Patient groups ...
Pharmabiz

NPPA releases price of 543 anti-cancer drugs under TMR with price cut upto over 90%, high priced drugs stay intact

NPPA releases price of 543 anti-cancer drugs under TMR with price cut upto over 90%, high priced drugs stay intact: Our Bureau, New Delhi Wednesday, October 28, 2026, 14:20 Hrs [I ...
Pharmabiz

Pandorum & Nucelion ink manufacturing pact to advance two designer-exosome programmes in ophthalmology with PRIP

Pandorum & Nucelion ink manufacturing pact to advance two designer-exosome programmes in ophthalmology with PRIP: Our Bureau, Bengaluru Wednesday, October 28, 2026, 13:45 Hrs [IST ...
Pharmabiz

SCHOTT Poonawalla becomes SCHOTT Pharma India to propel domestic market presence with global capabilities

SCHOTT Poonawalla becomes SCHOTT Pharma India to propel domestic market presence with global capabilities: Our Bureau, Bengaluru Wednesday, October 28, 2026, 14:30 Hrs [IST] Effec ...
Pharmabiz

New UK MHRA research?puts needle-free Strep A vaccine?within reach

New UK MHRA research?puts needle-free Strep A vaccine?within reach: United Kingdom Wednesday, October 28, 2026, 14:00 Hrs [IST] New research by the Medicines and Healthcare produc ...
Pharmabiz

US FDA granted expanded approval to Pfizer’s Talzenna plus Xtandi for an earlier metastatic prostate cancer treatment setting

US FDA granted expanded approval to Pfizer’s Talzenna plus Xtandi for an earlier metastatic prostate cancer treatment setting: New York Wednesday, October 28, 2026, 13:00 Hrs [I ...
Pharmabiz

Alembic Pharma receives US FDA final approval for valganciclovir for oral solution

Alembic Pharma receives US FDA final approval for valganciclovir for oral solution: Our Bureau, Mumbai Wednesday, October 28, 2026, 12:20 Hrs [IST] Alembic Pharmaceuticals Limited ...
Pharmabiz

AstraZeneca & Daiichi Sankyo’s Enhertu gets EU approval for adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast ...

AstraZeneca & Daiichi Sankyo’s Enhertu gets EU approval for adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast canc ...